Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ONCR Oncorus Inc

0.00 (0.00%)
Feb 29 2024 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 0
Bid Price 0.13
Ask Price 0.091
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Oncorus Inc ONCR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.12055 19:00:00
Open Price Low Price High Price Close Price Prev Close
0.12055 0.12055
Trades Volume Avg Volume 52 Week Range
0 0 - 0.0666 - 0.4299
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.12055 USD

Oncorus Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 3.15M - - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Oncorus News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No ONCR Message Board. Create One! See More Posts on ONCR Message Board See More Message Board Posts

Historical ONCR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months0.
6 Months0.
1 Year0.40820.42990.06660.12982343,518,590-0.28765-70.47%
3 Years15.8317.790.06661.36625,111-15.71-99.24%
5 Years15.5037.86030.06662.11552,734-15.38-99.22%

Oncorus Description

Oncorus Inc is a clinical-stage biopharmaceutical company focused on developing viral immunotherapies to transform outcomes for cancer patients. The company is in the process of developing intratumorally and intravenously administered product candidates designed to selectively attack and kill tumor cells and stimulate multiple arms of the immune system against tumors. Its pipeline product includes ONCR-177; ONCR-GBM; Coxsackievirus A21 and Seneca Valley Virus.

Your Recent History

Delayed Upgrade Clock